TIANJIN TOPTECH BIO SCIENCE & TECHNOLOGY CO LTD has a total of 13 patent applications. Its first patent ever was published in 2011. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are BELLICUM PHARMACEUTICALS INC, CHONGQING FAGEN BIOMEDICAL INC and HLA G TECHNOLOGIES.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | EPO (European Patent Office) | 1 | |
#4 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Zhang Xiaodong | 11 |
#2 | Ye Lihong | 11 |
#3 | Lihong Ye | 2 |
#4 | Xiaodong Zhang | 2 |
#5 | Shuai Zhang | 1 |
Publication | Filing date | Title |
---|---|---|
CN104744564A | Anti-hepatitis b virus X protein polypeptide drug | |
CN102358901A | Antitumor application of has-miR-520e | |
CN102746378A | Anti-fatty acid synthetase polypeptide and its application | |
CN102675423A | Polypeptide medicine against hepatitis B virus X protein | |
CN102675424A | Polypeptide drug for resisting Hepatitis B virus X protein | |
CN103992388A | Anti-hepatitis B virus X protein peptide medicament | |
CN102675422A | Polypeptide drug against hepatitis B virus X protein (HBx) |